UT San Antonio
Long School of Medicine

MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours

<p>MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours</p>

Share This Story